Gene · 2913
Papers2,242
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,242
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy. | Cells | 2021 | 34067762 | PubTator, text mining | PubMed |
| Workflows of the Single-Molecule Imaging Analysis in Living Cells: Tutorial Guidance to the Measurement of the Drug Effects on a GPCR. | Methods Mol Biol | 2021 | 34050488 | PubTator, text mining | PubMed |
| Frontal cortex genetic ablation of metabotropic glutamate receptor subtype 3 (mGlu3) impairs postsynaptic plasticity and modulates affective behaviors. | Neuropsychopharmacology | 2021 | 34035469 | PubTator, text mining | PubMed |
Systematic investigation of the pharmacological mechanism of Tanreqing injection in treating respiratory diseases by UHPLC/Q-TOF-MS/MS based on multiple in-house chemical libraries coupled with network pharmacology. | J Pharm Biomed Anal | 2021 | 34015594 | PubTator, text mining | PubMed |
| Transcriptome responses in polar cod (Boreogadus saida) liver slice culture exposed to benzo[a]pyrene and ethynylestradiol: insights into anti-estrogenic effects. | Toxicol In Vitro | 2021 | 34015484 | PubTator, text mining | PubMed |
| Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1. | J Transl Med | 2021 | 34001135 | PubTator, text mining | PubMed |
| Activating mGlu3 Metabotropic Glutamate Receptors Rescues Schizophrenia-like Cognitive Deficits Through Metaplastic Adaptations Within the Hippocampus. | Biol Psychiatry | 2021 | 33965197 | PubTator, text mining | PubMed |
| Studies of aging nonhuman primates illuminate the etiology of early-stage Alzheimer's-like neuropathology: An evolutionary perspective. | Am J Primatol | 2021 | 33960505 | PubTator, text mining | PubMed |
| Pathophysiological Mechanisms and Experimental Pharmacotherapy for L-Dopa-Induced Dyskinesia. | J Exp Pharmacol | 2021 | 33953618 | PubTator, text mining | PubMed |
| Efficacy and acquired resistance for EGFR-TKI plus thoracic SBRT in patients with advanced EGFR-mutant non-small-cell lung cancer: a propensity-matched retrospective study. | BMC Cancer | 2021 | 33931014 | PubTator, text mining | PubMed |
| Peripubertal mGluR2/3 Agonist Treatment Prevents Hippocampal Dysfunction and Dopamine System Hyperactivity in Adulthood in MAM Model of Schizophrenia. | Schizophr Bull | 2021 | 33928393 | PubTator, text mining | PubMed |
| Synaptic Reshaping and Neuronal Outcomes in the Temporal Lobe Epilepsy. | Int J Mol Sci | 2021 | 33917911 | PubTator, text mining | PubMed |
| Drugs Based on NMDAR Hypofunction Hypothesis in Schizophrenia. | Front Neurosci | 2021 | 33912003 | PubTator, text mining | PubMed |
| Mechanisms of differential desensitization of metabotropic glutamate receptors. | Cell Rep | 2021 | 33910009 | PubTator, text mining | PubMed |
| Differences in interactions between transmembrane domains tune the activation of metabotropic glutamate receptors. | Elife | 2021 | 33880992 | PubTator, text mining | PubMed |
| Receptors and Channels Associated with Alcohol Use: Contributions from Drosophila. | Neurosci Insights | 2021 | 33870197 | PubTator, text mining | PubMed |
| Circular RNA as a Potential Biomarker for Melanoma: A Systematic Review. | Front Cell Dev Biol | 2021 | 33869186 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals key pathways that vary in patients with paroxysmal and persistent atrial fibrillation. | Exp Ther Med | 2021 | 33850543 | PubTator, text mining | PubMed |
| Multi-omics reveals novel prognostic implication of SRC protein expression in bladder cancer and its correlation with immunotherapy response. | Ann Med | 2021 | 33830879 | PubTator, text mining | PubMed |
| Dysregulation of Ambient Glutamate and Glutamate Receptors in Epilepsy: An Astrocytic Perspective. | Front Neurol | 2021 | 33828523 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2913/papers?page=23